Stay updated on Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial

Sign up to get notified when there's something new on the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history, and the notice about a lapse in government funding as well as Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-11T02:37:12.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and updated the record to Revision 3.4.1; the previous Revision 3.4.0 was removed. These changes are administrative and do not affect core study data, eligibility criteria, or the availability of results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-03T23:50:29.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The update adds a glossary display and introduces color-coded change highlighting (green for additions, red for deletions) with the revision label updated to v3.4.0.
    Difference
    1%
    Check dated 2026-01-27T23:55:57.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A new revision entry v3.3.4 was added to the record history and the previous v3.3.3 entry was removed, a non-core update to the page history that does not affect the study data, status, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:16:18.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A new revision entry (Revision: v3.3.3) was added to the record history, and the HHS Vulnerability Disclosure link and the Revision: v3.3.2 entry were removed.
    Difference
    0.2%
    Check dated 2025-12-23T13:37:05.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Footer revision text updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T17:54:07.000Z thumbnail image

Stay in the know with updates to Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page.